Qilu Hospital , Shandong University
Jinan, Shandong, China
NCT Number: NCT04823780
The purpose of this study was to evaluate the safety of early enteral nutrition on endoscopic therapy of esophagogastric varices in Liver Cirrhosis ,and to assess the impact of different eating times on patients, so as to determine the best time for patients to obtain nutrition after surgery.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Jinan, Shandong, China
For patients with gastroesophageal varices in Liver Cirrhosis,, there is no clear guideline and consensus on when to start eating after endoscopic treatment. In 2015, a randomized controlled study in Taiwan of China confirmed that compared with liquid diet given 48 h after endoscopic treatment, liquid diet given 4 h and started enteral nutrition would not increase the risk of rebleeding, and could improve the nutritional status of patients. However, some patients after endoscopic treatment would suffer from post-sternal pain, abdominal pain, nausea, vomiting and other discomforts, affecting appetite and delay the diet time. Based on the above research background, we observed and evaluated the safety and effectiveness of early enteral nutrition in patients with cirrhotic esophageal and gastric varices after endoscopic treatment, and analyzed the influencing factors of enteral nutrition in patients with cirrhotic esophageal and gastric varices after endoscopic treatment, so as to further clarify the optimal time for patients to eat after endoscopic treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For the patients with esophageal and gastric varices after endoscopic treatment,start taking the nutrient solution at the fourth hour.
Time frame: 2 to 30days
the rate of rebleeding after endoscopic therapy
Qilu Hospital of Shandong University
Other
Investigation of the Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis:An Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02593799
Digestive System Diseases, Esophageal Diseases
Anshan, Liaoning, China
View Trial DetailsNCT00006398
Digestive System Diseases, Esophageal Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT00006161
Cardiovascular Diseases, Digestive System Diseases
Miami, Florida, United States
View Trial DetailsNCT07151885
Digestive System Diseases, Esophageal Diseases
Changchun, Jilin, China
View Trial Details